ArticleEuropean journal of obstetrics, gynecology, and reproductive biology2026
Familial risk of placental abruption.
Article in European journal of obstetrics, gynecology, and reproductive biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Gestational-Age Clustering of Recurrent Placental Abruption: A Multicenter Retrospective Descriptive Study.Journal of clinical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundPlacental abruption (PA), the partial or complete separation of the placenta before delivery, occurs in 1-2 % of pregnancies and is associated with severe maternal and perinatal morbidity and mortality. The etiology of PA is complex, and the increased recurrence risk in subsequent pregnancies suggests a potential genetic contribution. Investigating PA in large families may reveal important insights into inherited risk and the extent to which genetic factors contribute to PA. To guide future gene-discovery studies, we investigated the familial risk of PA using data from 1.2 million pregnancies across multi-generational families in the Utah Population Database.
objectiveTo estimate familial risk of PA using a large population database. STUDY
designWe conducted a population-based matched case-control study to examine familial risk of PA. PA cases (n = 32,823) and controls (n = 98,387) were ascertained using maternal death (1904-2020), fetal death (1904-2020) and fetal birth (1939-2020) certificates, and inpatient medical records (1996-2020) from the University of Utah Health Sciences Center. Three controls were matched to each case on maternal age, parity and number of relatives that were available in the database. PA risk for first-degree relatives (FDR), second-degree relatives (SDR), and third-degree relatives (TDR) of family members were estimated comparing cases and controls using generalized linear mixed-effect and conditional logistic regression models. Risk estimates were adjusted for the matching variables, year of pregnancy, maternal race/ethnicity and education level.
resultsOf 1,168,378 pregnancies analyzed in the Utah Population Database, 32,823 PA cases and controls (n = 98,387) were identified. FDRs, SDRs and TDRs had a 1.18-fold (95 % CI: 1.12-1.23), 1.09-fold (95 % CI: 1.06-1.13), and 1.01-fold (95 % CI: 0.99-1.03) increased PA risk when a family member experienced any PA, respectively. When family members experienced only one PA, FDRs, SDRs and TDRs had a 1.17-fold (95 % CI: 1.11-1.22), 1.09-fold (95 % CI: 1.05-1.13) and 1.01-fold (95 % CI: 0.98-1.03) increased PA risk, respectively. When family members experienced two or more PA, FDRs, SDRs and TDRs had a 1.38-fold (95 % CI: 1.17-1.64), 1.14-fold (95 % CI: 1.00-1.29) and 1.13-fold (95 % CI: 1.05-1.22) increased PA risk, respectively.
conclusionWe observed familial risk of PA even among distantly related individuals, extending beyond first-degree relationship, suggesting inherited risk factors contribute to PA. Genomic investigations in multi-generational families with PA, which provide more statistical power for gene discovery, may help identify pathogenic heritable mechanisms, leading to discovery of biomarkers and therapeutics to prevent PA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.